Study Evaluating Effexor XR for Major Depression.

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study Evaluating Effexor XR for Major Depression.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Levomilnacipran; Milnacipran; Venlafaxine Hydrochloride

Criteria

Inclusion Criteria:

• Patients diagnosed with major depression based on DSM-IV-TR

• Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" at the baseline.

Exclusion Criteria:

• Patients with schizophrenia or any other psychotic disorder

• Patients with history or presence of bipolar disorder